Monitor next quarterly filing (10-Q) for any changes in cash runway or pipeline progress. This board appointment alone does not alter the near-term trading thesis for this clinical-stage biotech.
Price Chart
Executive Summary
FibroBiologics appointed Leigh Steinberg, a prominent sports agent and longtime advocate for human longevity and brain health, to its Board of Directors on August 20, 2026. This is a routine board appointment with no material financial terms disclosed, and the filing contains no financial data, guidance, or operational updates. The event is neutral for the stock as it does not change the company's fundamental outlook or cash position.
Key Facts
- Leigh Steinberg appointed as Class II director effective August 20, 2026, term expiring at 2028 annual meeting.
- Steinberg will receive standard non-employee director compensation per company policy.
- Company entered into standard form indemnification agreement with Steinberg.
- No material financial data, guidance, or operational updates provided in the filing.
Financial Impact
No financial impact — standard director compensation, amounts not disclosed.
Risk Factors
- No financial data or operational catalysts provided; stock may continue to trade on cash runway and pipeline news.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-362027 |
| Document: 0001193125-26-362027-index.html | 0001193125-26-362027 |
| Document: 0001193125-26-362027.txt | 0001193125-26-362027 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 6d ago | EFFECT | $0.9199 | awaiting T+5 | — | $0.9221 (−0.24%) |
Oct 20, 2026 6d ago | EFFECT | $0.9199 | awaiting T+5 | — | $0.9221 (−0.24%) |
Oct 8, 2026 17d ago | 8-K | $1.13 $0.9710 | ▲ +14.07% | ▲ +12.10% | $0.9221 (+18.40%) |
Sep 15, 2026 5w ago | 8-K | $1.44 $1.43 | ▼ −0.69% | ▼ −1.51% | $0.9221 (−35.97%) |
Aug 24, 2026 9w ago | 8-K | $1.35 $1.72 | ▲ +27.41% | ▲ +26.94% | $0.9221 (−31.70%) |
Jul 31, 2026 12w ago | Press Release | $0.7910 $0.9800 | ▲ +23.89% | ▲ +21.87% | $0.9221 (+16.57%) |
Jul 17, 2026 14w ago | EFFECT | $0.8349 $0.7355 | ▲ +11.91% | ▲ +11.22% | $0.9221 (−10.44%) |
Jul 9, 2026 15w ago | 8-K | $0.8610 $0.8398 | ▼ −2.46% | ▼ −2.33% | $0.9221 (+7.10%) |
Jun 29, 2026 16w ago | 8-K | $0.9477 $0.8687 | ▲ +8.34% | ▲ +8.94% | $0.9221 (+2.70%) |
May 11, 2026 24w ago | Press Release | $0.9900 $1.09 | ▲ +10.10% | ▲ +10.19% | $0.9221 (−6.86%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers